doi:10.1016/j.jsxm.2022.09.002 Wang C, Swerdloff RS
"Appetite suppression and reduced food cravings [are] often noticeable within the first few weeks, followed by steady weight loss over several months." Dr
Just this past August, semaglutide was approved for treating metabolicassociated steatohepatitis, formerly known as fatty liver disease, says Dr
After four weeks with no changes to macros or training, bioimpedance scanning showed 6.3 pounds of fat loss and 1.1 pounds of lean mass gain simultaneously
Continued Growth in GLP-1 Compounding Despite Regulatory Headwinds Despite the resolution of GLP-1 shortages and increased regulatory scrutiny, compounded prescriptions for semaglutide and tirzepatide continue to rise
Gault V, Porter W, Flatt P, et al